A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia

NCT01808326 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukaemia, Lymphoblastic

Interventions

DRUG: chlorambucil, tablets

Sponsor

GlaxoSmithKline